Antiasthmatics and bronchospasmolytics Bronchospasmolytics are used to treat bronchial asthma and chronic obstructive pulmonary disease (COPD). Bronchospasmolytics are used to treat bronchial asthma and chronic obstructive pulmonary disease (COPD). The aim of both diseases is to reduce bronchial obstruction, which is more reversible in asthma than in COPD. In the late stages of COPD with respiratory insufficiency, emphysema and corpulmonary emphysema, the symptoms should be improved as much as possible. Prescription profile Beta-sympathomimetics traditionally form the largest group of drugs in asthma therapy. Another important group of drugs are inhaled glucocorticoids, which are mainly prescribed in combination with long-acting beta-sympathomimetics.